1-241497861-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000143.4(FH):c.1500G>A(p.Trp500Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Consequence
FH
NM_000143.4 stop_gained
NM_000143.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 5.75
Genes affected
FH (HGNC:3700): (fumarate hydratase) The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0215 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-241497861-C-T is Pathogenic according to our data. Variant chr1-241497861-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 265151.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-241497861-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.1500G>A | p.Trp500Ter | stop_gained | 10/10 | ENST00000366560.4 | NP_000134.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FH | ENST00000366560.4 | c.1500G>A | p.Trp500Ter | stop_gained | 10/10 | 1 | NM_000143.4 | ENSP00000355518 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary leiomyomatosis and renal cell cancer Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Jan 17, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2017 | This variant is denoted FH c.1500G>A at the cDNA level and p.Trp500Ter (W500X) at the protein level. The substitution creates a nonsense variant, which changes a Tryptophan to a premature stop codon (TGG>TGA), and is predicted to cause loss of normal protein function through protein truncation. Also published as FH c.1371G>A (p.Trp457X) using alternate nomenclature, this variant has been reported in a large family with HLRCC as well as in an individual with a single cutaneous leiomyoma (Gardie 2011, Buelow 2016). In addition, the adjacent nucleotide change resulting in the same nonsense variant c.1499G>A (p.W500X), reported as p.W458X using alternate nomenclature, was identified in the compound heterozygous state with another FH variant in a child with fumarate hydratase deficiency and significantly decreased FH enzyme activity (Coughlin 1998). Based on currently available evidence, we consider FH c.1500G>A to be pathogenic. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 13, 2021 | The p.W500* pathogenic variant (also known as c.1500G>A), located in coding exon 10 of the FH gene, results from a G to A substitution at nucleotide position 1500. This changes the amino acid from a tryptophan to a stop codon within coding exon 10. This alteration occurs at the 3' terminus of theFH gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 2%/10 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This alteration disrupts normal FH folding and is anticipated to result in a significant decrease in structural stability (Ambry internal data). This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with FH-related disease and segregates with disease in one of these families (Ambry internal data; Gardie B et al. J. Med. Genet., 2011 Apr;48:226-34; Buelow B et al. Am. J. Surg. Pathol., 2016 07;40:982-8). This alteration is also referred to as p.Trp457X (c.1371G>A) in the literature. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at